ZGN-1061: Clinical Trials

1 trial of ZGN-1061, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow ZGN-1061: new trials by email Literature Review of ZGN-1061 trials Research Report on ZGN-1061

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes
ZGN-1061, Placebo - Type 2 Diabetes Mellitus, Overweight and Obesity
Phase 2CompletedZafgen, Inc.1882017-09-122019-05-24

Conditions studied

Diabetes Mellitus, Type 2 (1)  ·  Obesity (1)  ·  Overweight (1)

Sponsors

Zafgen, Inc. (1)

Countries

Australia (1)  ·  New Zealand (1)

Top investigators

Dennis Kim, MD (1)